Trial
NCT00659334
Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Condition
Brain Neoplasms
Intervention
Ferumoxtran-10 (Combidex)
Why stopped
AMAG not continuing with Combidex, the study drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-21